PLANO, Texas – Pharmaceutical Strategies Group (PSG), a leading pharmacy intelligence and technology company providing innovative drug management solutions to hospitals, health systems, health plans and employers, was recently named #65 on the 29th annual SMU Cox Dallas 100TM list of fastest-growing, privately-held companies in the Dallas Metroplex.
“We are honored to be named to the prestigious Dallas 100,” said Dave Borden, CEO of PSG. “This achievement is a reflection of our team – each of whom has played a role in our success. Our employees are dedicated to relentlessly advocating for our clients and helping them to manage drug costs. As we celebrate our company’s 25-year history, and our third year in a row on the Inc 5000, I believe it’s our team’s passion for our mission and our clients that is fueling our continued growth.”
The Cox School’s Caruth Institute for Entrepreneurship annually ranks the top 100 Dallas privately-held entrepreneurial companies based on percentage growth and absolute dollar growth over the previous three years. The Institute, working with the accounting firm BKD LLP CPAs and Advisors examined sales from hundreds of companies for 2016 to 2018, the most recent year for which complete data is available.
“These companies are the unsung heroes of the Dallas-area economy,” said Simon Mak, the Linda A. and Kenneth R. Morris Endowed Director of the Caruth Institute for Entrepreneurship at SMU Cox. “They are entrepreneurial dynamos, creating products and/or services that in turn create jobs and generate income, not to mention the millions of dollars they collectively contribute to our economy.”
Dallas 100™, co-founded by the SMU Cox Caruth Institute, honors the ingenuity, commitment and perseverance of the fastest-growing privately held entrepreneurial businesses in the Dallas area. This year’s winning companies collectively generated $3.5 billion in sales in 2018, according to Mak.